COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases.

Abstract

BACKGROUND:

Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy.

CASE PRESENTATION:

We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.

CONCLUSION:

We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19.

• Authors: Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ahmadinejad, Samaneh Tirgar, Seyed Ahmad Seyed Alinaghi
• Journal: Infectious disorders drug targets (Infect Disord Drug Targets) Vol. 21 Issue 6 Pg. e170721188439 ( 2021) ISSN: 2212-3989 [Electronic] United Arab Emirates
• PMID: 33243134 (Publication Type: Case Reports)
• Copyright: Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Chemical References

• Hydroxychloroquine
• Azithromycin

Topics

• Azithromycin (therapeutic use)
• Humans
• Hydroxychloroquine
• SARS-CoV-2
• COVID-19 Drug Treatment